Congenital Heart Futures Reauthorization Act of 2017

Health care quality; physician and hospital quality; health care innovation; Patient Protection and Affordable Care Act/health care reform implementation; Affordable Care Act repeal/replace/reform efforts; medical liability reform, including HR 1215, the Protecting Access to Care Act; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; clinical data registries; the Common Rule and registries; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, FDA, HRSA and the Childrens Hospital Graduate Medical Education payment program, including H.R. 5385, the Prevention & Public Health Fund, medical research, and prevention; HR 3592, the South Asian Heart Health Awareness and Research Act of 2017; research and scholarly communication policy, including S 1701/HR 3427, the Fair Access to Science and Technology Research Act of 2017; healthy diet/lifestyle; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; S 477/HR 1222, the Congenital Heart Futures Reauthorization Act of 2017; National Clinical Care Commission Act implementation; Senate price transparency workgroup; reduction/oversight of prior authorization and other administrative burdens; shared decision-making; medical isotope production and supply; digital health/FDA pre-certification; cardiomyopathy education and awareness.

Client expense: $750,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office

Common Sense Nutrition Disclosure Act(S.261/H.R.772) Congenital Heart Futures Reauthorization Act of 2017(H.R.1222/S.477) H.Res 827- Expressing Support for designation of April 2018 as "National Donate Life Month" Health equity and accountability Act of 2018(no bill # introduced 5/23) H.R.3592 South Asian Heart Health Awareness and Research Act of 2017 H.R.1313, the Preserving Employer Wellness Programs Act Prevention and Public Health Fund(ACA Section 4002) Personal Health Investment Today Act(PHIT)(S.482/H.R.1267) Regulatory Accountability Act(S.951) S.3388- Ensuring Coverage for Patients with Pre-Existing Conditions Act S.Res479- A resolution designating April 2018 as "National Donate Life Month"

Client expense: $110,535 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

American Health Care Act of 2017 (HR 1628) Health Care Safety Net Enhancement Act (HR 548) Congenital Heart Futures Reauthorization Act (S 477/HR 1222) USPSTF Transparency and Accountability Act (HR 539) Protecting Access to Care Act of 2017 (HR 1215) Resident Physician Shortage Reduction Act of 2017 (HR2267/S.1301) Prohibit Smoking in VA Facilities Act (H.R.1662) The Veterans Affairs Medical Scribe Pilot Act of 2017 (H.R. 1848) Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Medicare Access and CHIP Reauthorization Act of 2015 Implementation, Medicare Physician Payment Reform, MEDPAC, surgical global payments, Affordable Care Act Implementation, Affordable Care Act Repeal & Replace, health care reform, health care quality improvement, physician workforce, comparative effectiveness research, health information technology, EHR meaningful use, EHR data blocking, Patient-Centered Outcomes Research Institute, MEDCAC, Centers for Medicare & Medicaid Innovation, registry access to Medicare claims data, Social Security Death Master File, lung cancer screenings, AHRQ funding, USPSTF, Graduate Medical Education, electronic cigarette and cigar regulation, Physician-Focused Payment Model Technical Advisory Committee (PTAC), Proposed Medical Device Surveillance System, Meaningful Use, Congenital Heart Disease Funding, Unique Device Identifiers, Medical Liability Reform, essential health benefits, tobacco riders in appropriations bills, tobacco regulation in the FDA, Evaluation and Management coding collapse, price transparency

Client expense: $104,000 · Firm income: Not reported

Congenital Heart Futures Act Reauthorization; HR 1222, S 477 Patient Access to Care

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

Health care quality; physician and hospital quality; health care innovation; Patient Protection and Affordable Care Act/health care reform implementation; Affordable Care Act repeal/replace/reform efforts; medical liability reform, including HR 1215, the Protecting Access to Care Act; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; clinical data registries; the Common Rule and registries; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, FDA, HRSA and the Childrens Hospital Graduate Medical Education payment program, the Prevention & Public Health Fund, medical research, and prevention; HR 3592, the South Asian Heart Health Awareness and Research Act of 2017; research and scholarly communication policy, including S 1701/HR 3427, the Fair Access to Science and Technology Research Act of 2017; healthy diet/lifestyle; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; S 477/HR 1222, the Congenital Heart Futures Reauthorization Act of 2017; National Clinical Care Commission Act implementation; Senate price transparency workgroup; reduction/oversight of prior authorization and other administrative burdens; shared decision-making; medical isotope production and supply.

Client expense: $380,000 · Firm income: Not reported

American Health Care Act of 2017 (HR 1628) Health Care Safety Net Enhancement Act (HR 548) Congenital Heart Futures Reauthorization Act (S 477/HR 1222) USPSTF Transparency and Accountability Act (HR 539) Protecting Access to Care Act of 2017 (HR 1215) Resident Physician Shortage Reduction Act of 2017 (HR2267/S.1301) Prohibit Smoking in VA Facilities Act (H.R.1662) The Veterans Affairs Medical Scribe Pilot Act of 2017 (H.R. 1848) Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Medicare Access and CHIP Reauthorization Act of 2015 Implementation, Medicare Physician Payment Reform, MEDPAC, surgical global payments, Affordable Care Act Implementation, Affordable Care Act Repeal & Replace, health care reform, health care quality improvement, physician workforce, comparative effectiveness research, health information technology, EHR meaningful use, Patient-Centered Outcomes Research Institute, MEDCAC, Centers for Medicare & Medicaid Innovation, Medicare claims data, Social Security Death Master File, lung cancer screenings, AHRQ funding, USPSTF, Graduate Medical Education, electronic cigarette and luxury cigar regulation, Physician-Focused Payment Model Technical Advisory Committee (PTAC), Proposed Medical Device Surveillance System, Meaningful Use, Congenital Heart Disease Funding, Unique Device Identifiers, Medical Liability Reform, essential health benefits, tobacco riders in appropriations bills, tobacco regulation in the FDA

Client expense: $115,000 · Firm income: Not reported

Common Sense Nutrition Disclosure Act(S.261/H.R.772) Congenital Heart Futures Reauthorization Act of 2017(H.R.1222/S.477) H.Res 827- Expressing Support for designation of April 2018 as "National Donate Life Month" Health equity and accountability Act of 2018(no bill # introduced 5/23) H.R.3592 South Asian Heart Health Awareness and Research Act of 2017 H.R.1313, the Preserving Employer Wellness Programs Act Prevention and Public Health Fund(ACA Section 4002) Personal Health Investment Today Act(PHIT)(S.482/H.R.1267) Regulatory Accountability Act(S.951) S.Res479- A resolution designating April 2018 as "National Donate Life Month"

Client expense: $102,265 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

Congenital Heart Futures Act Reauthorization; HR 1222, S 477 Patient Access to Care

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

Health care quality; physician and hospital quality; Patient Protection and Affordable Care Act/health care reform implementation; Affordable Care Act repeal/replace/reform efforts, including the American Health Care Act, the Better Care Reconciliation Act, S 1835, the Lower Premiums Through Reinsurance Act of 2017, and the Graham/Cassidy amendment to the American Health Care Act; medical liability reform, including HR 1215, the Protecting Access to Care Act; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; clinical data registries; the Common Rule and registries; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, HRSA, FDA, the Prevention & Public Health Fund, medical research, and prevention, including the Bipartisan Budget Act of 2018, HR 1892, and HR 1625, the Consolidated Appropriations Act of 2018; HR 3592, the South Asian Heart Health Awareness and Research Act of 2017; research and scholarly communication policy, including S 1701/HR 3427, the Fair Access to Science and Technology Research Act of 2017; healthy diet/lifestyle; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; S 477/HR 1222, the Congenital Heart Futures Reauthorization Act of 2017; National Clinical Care Commission Act implementation; Senate price transparency workgroup; reduction/oversight of prior authorization and other administrative burdens; shared decision-making; disaster relief funding; medical isotope production and supply; tax reform legislation and related issues, including HR 1, the Tax Cuts and Jobs Act.

Client expense: $490,000 · Firm income: Not reported

American Health Care Act of 2017 (HR 1628) Health Care Safety Net Enhancement Act (HR 548) Congenital Heart Futures Reauthorization Act (S 477/HR 1222) USPSTF Transparency and Accountability Act (HR 539) Protecting Access to Care Act of 2017 (HR 1215) Resident Physician Shortage Reduction Act of 2017 (HR2267/S.1301) Prohibit Smoking in VA Facilities Act (H.R.1662) The Veterans Affairs Medical Scribe Pilot Act of 2017 (H.R. 1848) Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Medicare Access and CHIP Reauthorization Act of 2015 Implementation, Medicare Physician Payment Reform, MEDPAC, surgical global payments, Affordable Care Act Implementation, Affordable Care Act Repeal & Replace, health care reform, health care quality improvement, physician workforce, comparative effectiveness research, health information technology, EHR meaningful use, Patient-Centered Outcomes Research Institute, MEDCAC, Centers for Medicare & Medicaid Innovation, Medicare claims data, Social Security Death Master File, lung cancer screenings, AHRQ funding, USPSTF, Graduate Medical Education, electronic cigarette and luxury cigar regulation, Physician-Focused Payment Model Technical Advisory Committee (PTAC), Proposed Medical Device Surveillance System, Meaningful Use, Congenital Heart Disease Funding, Unique Device Identifiers, Medical Liability Reform, essential health benefits, tobacco riders in appropriations bills

Client expense: $90,000 · Firm income: Not reported

American Health Care Act American Heart Month Resolution(S.Res.45) Better Reconciliation Act of 2017 Common Sense Nutrition Disclosure Act(S.261/H.R.772) Congenital Heart Futures Reauthorization Act of 2017(H.R.1222/S.477) Graham Cassidy H.Res.752-Recognizing the rise of cardiovascular disease as the world's leading cause of preventable death and disability and as the global public health crisis of our generation and recognizing February 2018 as "American Heart Month" H.R.3592 South Asian Heart Health Awareness and Research Act of 2017 H.R.1313, the Preserving Employer Wellness Programs Act Menu Labeling(ACA Section 4205) Prevention and Public Health Fund(ACA Section 4002) Personal Health Investment Today Act(PHIT)(S.482/H.R.1267) RAISE Family Caregivers Act(S.354/H.R.987) Regulatory Accountability Act(S.951) S.Res.403-A resolution designating February 2018 as "American Heart Month" and February 2, 2018, as "National Wear Red Day" Tax Cuts and Jobs Act(H.R.1)(P.L.115-97)

Client expense: $45,380 · Firm income: Not reported

Congenital Heart Futures Act Reauthorization; HR 1222, S 477 Patient Access to Care

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

American Health Care Act of 2017 (HR 1628) Health Care Safety Net Enhancement Act (HR 548) Congenital Heart Futures Reauthorization Act (S 477/HR 1222) USPSTF Transparency and Accountability Act (HR 539) Protecting Access to Care Act of 2017 (HR 1215) Resident Physician Shortage Reduction Act of 2017 (HR2267) Prohibit Smoking in VA Facilities Act (H.R.1662) Medicare Access and CHIP Reauthorization Act of 2015 Implementation, Medicare Physician Payment Reform, MEDPAC, surgical global payments, Affordable Care Act Implementation, Affordable Care Act Repeal & Replace, health care reform, health care quality improvement, physician workforce, comparative effectiveness research, health information technology, EHR meaningful use, Patient-Centered Outcomes Research Institute, MEDCAC, Centers for Medicare & Medicaid Innovation, Medicare claims data, Social Security Death Master File, lung cancer screenings, AHRQ funding, USPSTF, Graduate Medical Education, electronic cigarette regulation, Physician-Focused Payment Model Technical Advisory Committee (PTAC), Proposed Medical Device Surveillance System, Meaningful Use, Congenital Heart Disease Funding, Unique Device Identifiers, Medical Liability Reform, essential health benefits, tobacco riders in appropriations bills

Client expense: $119,000 · Firm income: Not reported

American Health Care Act of 2017 (HR 1628) Health Care Safety Net Enhancement Act (HR 548) Congenital Heart Futures Reauthorization Act (S 477/HR 1222) USPSTF Transparency and Accountability Act (HR 539) Protecting Access to Care Act of 2017 (HR 1215) Resident Physician Shortage Reduction Act of 2017 (HR2267) Prohibit Smoking in VA Facilities Act (H.R.1662) Medicare Access and CHIP Reauthorization Act of 2015 Implementation, Medicare Physician Payment Reform, MEDPAC, surgical global payments, Affordable Care Act Implementation, Affordable Care Act Repeal & Replace, health care reform, health care quality improvement, physician workforce, comparative effectiveness research, health information technology, EHR meaningful use, Patient-Centered Outcomes Research Institute, MEDCAC, Centers for Medicare & Medicaid Innovation, Medicare claims data, Social Security Death Master File, lung cancer screenings, AHRQ funding, USPSTF, Graduate Medical Education, electronic cigarette regulation, Physician-Focused Payment Model Technical Advisory Committee (PTAC), Proposed Medical Device Surveillance System, Meaningful Use, Congenital Heart Disease Funding, Unique Device Identifiers, Medical Liability Reform, essential health benefits, tobacco riders in appropriations bills

Client expense: $119,000 · Firm income: Not reported

Organ Transplant Discrimination "Kevin and Avonte's Law (S. 2070/H.R. 4221) Congenital Heart Futures Act (S.477/H.R.1222)

Client expense: Not reported · Firm income: $10,500

Government targets: HOUSE OF REPRESENTATIVES, SENATE

American Health Care Act of 2017 (HR 1628) Health Care Safety Net Enhancement Act (HR 548) Congenital Heart Futures Reauthorization Act (S 477/HR 1222) USPSTF Transparency and Accountability Act (HR 539) Protecting Access to Care Act of 2017 (HR 1215) Resident Physician Shortage Reduction Act of 2017 (HR2267/S.1301) Prohibit Smoking in VA Facilities Act (H.R.1662) The Veterans Affairs Medical Scribe Pilot Act of 2017 (H.R. 1848) Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Medicare Access and CHIP Reauthorization Act of 2015 Implementation, Medicare Physician Payment Reform, MEDPAC, surgical global payments, Affordable Care Act Implementation, Affordable Care Act Repeal & Replace, health care reform, health care quality improvement, physician workforce, comparative effectiveness research, health information technology, EHR meaningful use, Patient-Centered Outcomes Research Institute, MEDCAC, Centers for Medicare & Medicaid Innovation, Medicare claims data, Social Security Death Master File, lung cancer screenings, AHRQ funding, USPSTF, Graduate Medical Education, electronic cigarette and luxury cigar regulation, Physician-Focused Payment Model Technical Advisory Committee (PTAC), Proposed Medical Device Surveillance System, Meaningful Use, Congenital Heart Disease Funding, Unique Device Identifiers, Medical Liability Reform, essential health benefits, tobacco riders in appropriations bills

Client expense: $91,000 · Firm income: Not reported

American Health Care Act American Heart Month Resolution(S.Res.45) Better Reconciliation Act of 2017 CHAMPION Act(H.R.3922) Common Sense Nutrition Disclosure Act(S.261/H.R.772) Congenital Heart Futures Reauthorization Act of 2017(H.R.1222/S.477) Credit for Caring Act(S.1151) Graham Cassidy H.R.1313, the Preserving Employer Wellness Programs Act Menu Labeling(ACA Section 4205) Prevention and Public Health Fund(ACA Section 4002) Personal Health Investment Today Act(PHIT)(S.482/H.R.1267) RAISE Family Caregivers Act(S.354/H.R.987) Regulatory Accountability Act(S.951) Tax Cuts and Jobs Act(H.R.1)(P.L.115-97)

Client expense: $40,713 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

Congenital Heart Futures Act Reauthorization; HR 1222, S 477 Patient Access to Care

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

Health care quality; physician and hospital quality; Patient Protection and Affordable Care Act/health care reform implementation; Affordable Care Act repeal/replace/reform efforts, including the American Health Care Act, the Better Care Reconciliation Act, S 1835, the Lower Premiums Through Reinsurance Act of 2017, and the Graham/Cassidy amendment to the American Health Care Act; medical liability reform, including HR 1215, the Protecting Access to Care Act; unique device identifier policy and post-market surveillance for medical devices; FDA User Fee Program reauthorization; clinical trial design; clinical data registries; the Common Rule and registries; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, HRSA, FDA, the Prevention & Public Health Fund, medical research, and prevention; HR 3592, the South Asian Heart Health Awareness and Research Act of 2017; research and scholarly communication policy, including S 1701/HR 3427, the Fair Access to Science and Technology Research Act of 2017; healthy diet/lifestyle; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; S 477/HR 1222, the Congenital Heart Futures Reauthorization Act of 2017; HR 309/S 920, the National Diabetes Clinical Care Commission Act; reduction of administrative burdens; disaster relief funding; medical isotope production and supply; tax reform legislation and related issues, including HR 1, the Tax Cuts and Jobs Act.

Client expense: $440,000 · Firm income: Not reported

American Health Care Act of 2017 (HR 1628) Health Care Safety Net Enhancement Act (HR 548) Congenital Heart Futures Reauthorization Act (S 477/HR 1222) USPSTF Transparency and Accountability Act (HR 539) Protecting Access to Care Act of 2017 (HR 1215) Resident Physician Shortage Reduction Act of 2017 (HR2267/S.1301) Prohibit Smoking in VA Facilities Act (H.R.1662) The Veterans Affairs Medical Scribe Pilot Act of 2017 (H.R. 1848) Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Medicare Access and CHIP Reauthorization Act of 2015 Implementation, Medicare Physician Payment Reform, MEDPAC, surgical global payments, Affordable Care Act Implementation, Affordable Care Act Repeal & Replace, health care reform, health care quality improvement, physician workforce, comparative effectiveness research, health information technology, EHR meaningful use, Patient-Centered Outcomes Research Institute, MEDCAC, Centers for Medicare & Medicaid Innovation, Medicare claims data, Social Security Death Master File, lung cancer screenings, AHRQ funding, USPSTF, Graduate Medical Education, electronic cigarette regulation, Physician-Focused Payment Model Technical Advisory Committee (PTAC), Proposed Medical Device Surveillance System, Meaningful Use, Congenital Heart Disease Funding, Unique Device Identifiers, Medical Liability Reform, essential health benefits, tobacco riders in appropriations bills

Client expense: $109,000 · Firm income: Not reported

American Health Care Act American Heart Month Resolution(S.Res.45) Better Reconciliation Act of 2017 CHAMPION Act(H.R.3922) Common Sense Nutrition Disclosure Act(S.261/H.R.772) Congenital Heart Futures Reauthorization Act of 2017(H.R.1222/S.477) Credit for Caring Act(S.1151) Graham Cassidy Menu Labeling(ACA Section 4205) Prevention and Public Health Fund(ACA Section 4002) Personal Health Investment Today Act(PHIT)(S.482/H.R.1267) RAISE Family Caregivers Act(S.354/H.R.987) Regulatory Accountability Act(S.951)

Client expense: $41,981 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

Health care quality; physician and hospital quality; Patient Protection and Affordable Care Act/health care reform implementation; Affordable Care Act repeal/replace reform efforts, including the American Health Care Act, the Better Care Reconciliation Act and the Graham/Cassidy amendment to the American Health Care Act; medical liability reform, including HR 1215, the Protecting Access to Care Act; unique device identifier policy and post-market surveillance for medical devices; FDA reauthorization; clinical trial design; clinical data registries; the Common Rule and registries; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, HRSA, FDA, the Prevention & Public Health Fund, medical research, and prevention; healthy diet/lifestyle; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; S 477/HR 1222, the Congenital Heart Futures Reauthorization Act of 2017; HR 309/S 920, the National Diabetes Clinical Care Commission Act; HR 3120, a bill to amend title XVIII of the Social Security Act to reduce the volume of future electronic health record-related significant hardship requests; reduction of administrative burdens; disaster relief funding.

Client expense: $730,000 · Firm income: Not reported

Congenital Heart Futures Act Reauthorization; HR 1222, S 477 American Health Care Act, HR 1628 Better Care Reconciliation Act, HR 1628 Cassidy-Graham

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

American Health Care Act American Heart Month Resolution(S.Res.45/H.R.146) Better Reconciliation Act of 2017 Common Sense Nutrition Disclosure Act(S.261/H.R.772) Congenital Heart Futures Reauthorization Act of 2017(H.R.1222/S.477) Credit for Caring Act(S.1151) Menu Labeling(ACA Section 4205) Prevention and Public Health Fund(ACA Section 4002) Personal Health Investment Today Act(PHIT)(S.482/H.R.1267) RAISE Family Caregivers Act(S.354/H.R.987) Regulatory Accountability Act(S.951)

Client expense: $142,995 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

Health care quality; physician and hospital quality; Patient Protection and Affordable Care Act/health care reform implementation; Affordable Care Act repeal/replace reform efforts, including the American Health Care Act and the Better Care Reconciliation Act; medical liability reform, including HR 1215, the Protecting Access to Care Act; unique device identifier policy and post-market surveillance for medical devices; FDA reauthorization; clinical trial design; clinical data registries; the Common Rule and registries; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, HRSA, FDA, the Prevention & Public Health Fund, medical research, and prevention; healthy diet/lifestyle; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; S 477/HR 1222, the Congenital Heart Futures Reauthorization Act of 2017; HR 309, the National Diabetes Clinical Care Commission Act.

Client expense: $430,000 · Firm income: Not reported

American Health Care Act of 2017 (HR 1628) Health Care Safety Net Enhancement Act (HR 548) Congenital Heart Futures Reauthorization Act (S 477/HR 1222) USPSTF Transparency and Accountability Act (HR 539) Protecting Access to Care Act of 2017 (HR 1215) Resident Physician Shortage Reduction Act of 2017 (HR2267) Prohibit Smoking in VA Facilities Act (H.R.1662) Medicare Access and CHIP Reauthorization Act of 2015 Implementation, Medicare Physician Payment Reform, MEDPAC, surgical global payments, Affordable Care Act Implementation, Affordable Care Act Repeal & Replace, health care reform, health care quality improvement, physician workforce, comparative effectiveness research, health information technology, EHR meaningful use, Patient-Centered Outcomes Research Institute, MEDCAC, Centers for Medicare & Medicaid Innovation, Medicare claims data, Social Security Death Master File, lung cancer screenings, AHRQ funding, USPSTF, Graduate Medical Education, electronic cigarette regulation, Physician-Focused Payment Model Technical Advisory Committee (PTAC), Proposed Medical Device Surveillance System, Meaningful Use, Congenital Heart Disease Funding, Unique Device Identifiers, Medical Liability Reform, essential health benefits, tobacco riders in appropriations bills

Client expense: $119,000 · Firm income: Not reported

Congenital Heart Futures Act Reauthorization; HR 1222, S 477 American Health Care Act, HR 1628 Better Care Reconciliation Act

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

American Health Care Act (H.R. 1628) Congenital Heart Futures Reauthorization Act (H.R. 1222/S. S. 477)

Client expense: Not reported · Firm income: $9,500

Government targets: HOUSE OF REPRESENTATIVES, SENATE

American Health Care Act American Heart Month Resolution(S.Res.45/H.R.146) Common Sense Nutrition Disclosure Act(S.261/H.R.772) Congenital Heart Futures Reauthorization Act of 2017(H.R.1222/S.477) Menu Labeling(ACA Section 4205) Prevention and Public Health Fund(ACA Section 4002) Personal Health Investment Today Act(PHIT)(S.482/H.R.1267) RAISE Family Caregivers Act(S.354/H.R.987)

Client expense: $273,178 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

Legislation; HR 2896, Taking Account of Institutions with Low Operation Risk Act of 2015; H.R. 766, the Financial Institution Customer Protection Act of 2015; All legislation concerning budget views or appropriations, including concerning riders on independent funding, structure and authority of CFPB (Financial Services and General Government Appropriations (HR5485/S2663); riders on transportation safety and airline fee disclosure. All legislation concerning amendments to DoddFrank Wall Street Reform and Consumer Protection Act, including authority of agencies to enforce laws to protect consumers, taxpayers. H.R.4781 FDIC Accountability Act of 2016; HR 1265, Bureau Advisory Commission Transparency Act; HR 1263, Consumer Financial Protection Safety and Soundness Improvement Act of 2015; HR 1262, Consumer Right to Financial Privacy Act of 2015; HR 1264, CFPB Pay Fairness Act of 2015; HR 1261, Bureau of Consumer Financial Protection Accountability Act of 2015; HR 1413/S477, Firearms Manufacturers and Dealers Protection Act of 2015 (FDIC Operation Choke Point); H.R. 766 and S2790, the Financial Institution Customer Protection Act of 2015. HR 5510, to weaken FTC; HR 4768 Separation of Powers Restoration Act; other riders and amendments to weaken independent agency authority to enact regulations. HR4172 Full file credit reporting; HR5282 Fair Credit Reporting Act amendments. Department of Education Gainful Employment rule. including HR4768, the Separation of Powers Restoration Act; HR4612 and sections of HR4361 concerning the Midnight Rules Relief Act; S2355, the Credit Access and Inclusion Act; HR5424, the Investment Advisors Modernization Act; HR5226, the Regulatory Integrity Act; HR3468, The Review Act; HR5063, the Stop Settlement Funds Act and any similar riders proposed to Appropriations Bills such as HR5485/SB3067, Financial Services and General Government Appropriations Acts for 2017. File comments to CFPB on Docket 20160020 on forced arbitration; file comment to CFPB on announcement of Debt Collection rulemaking SBREFA process; meet with CFPB on consumer complaint database, payday lending and other matters. File comment to financial and bank regulators on status of completion of rulemaking on DoddFrank Section 956, Executive Compensation; All legislation pertaining to the Consumer Financial Protection Bureau, including to restrict its authorities, change its structure to a commission or modify its independent funding and all proposals to implement the Congressional Review Act to rescind CFPB rules, including the prepaid card rule of October 2016; comment on all rules proposed by the CFPB, including its high-cost (payday) and arbitration draft rules. Comment on all Executive Orders and Requests for Information pertaining to changing or limiting the structure of US Financial Regulation system. All agency proposed rules, requests for Information or guidances concerning "fintech" firms and their chartering. Oppose all appropriations riders to subject independent agencies to restrictive, duplicative regulatory cost-benefit analysis and OMB/OIRA oversight. Bills include HR103/S370, S365, S387, S105, S626, S552/HR1414, HR50, HR1116/S366, HR1018 and SJR19/HJR73/HJR62.

Health care quality; physician and hospital quality; Patient Protection and Affordable Care Act/health care reform implementation; health care reform, including HR 1628, the American Health Care Act; medical liability reform, including HR 1215, the Protecting Access to Care Act; Physician Sunshine/Open Payments; informed consent and FDA-related research; unique device identifier policy and post-market surveillance for medical devices; Medical Device User Fee Act reauthorization; clinical data registries; the Common Rule and registries; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, HRSA, FDA, medical research, and prevention; healthy diet/lifestyle; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; S 477/HR 1222, the Congenital Heart Futures Reauthorization Act of 2017; HR 309, the National Diabetes Clinical Care Commission Act.

Client expense: $350,000 · Firm income: Not reported

American Health Care Act of 2017 (HR 1628) Good Samaritan Health Professional Act (HR 1822) Health Care Safety Net Enhancement Act (HR 548) Congenital Heart Futures Reauthorization Act (S 477) USPSTF Transparency and Accountability Act (HR 539) Medicare Access and CHIP Reauthorization Act of 2015 Implementation, Medicare Physician Payment Reform, MEDPAC, surgical global payments, Affordable Care Act Implementation, Affordable Care Act Repeal & Replace, health care reform, health care quality improvement, physician workforce, comparative effectiveness research, health information technology, EHR meaningful use, Patient-Centered Outcomes Research Institute, MEDCAC, Centers for Medicare & Medicaid Innovation, Medicare claims data, Social Security Death Master File, lung cancer screenings, AHRQ funding, USPSTF, Graduate Medical Education, electronic cigarette regulation, Physician-Focused Payment Model Technical Advisory Committee (PTAC), Proposed Medical Device Surveillance System, Meaningful Use, Congenital Heart Disease Funding, Unique Device Identifiers, Medical Liability Reform, essential health benefits, tobacco riders in appropriations bills

Client expense: $110,000 · Firm income: Not reported

Congenital Heart Futures Act Reauthorization; HR 1222, S 477

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE